Zobrazeno 1 - 10
of 37
pro vyhledávání: '"S, spike protein"'
Autor:
Mahmoud M. Berekaa
Publikováno v:
Frontiers in Bioscience-Elite, Vol 13, Iss 1, Pp 117-139 (2020)
Coronavirus disease (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a member of the human coronavirus (HCoV) family that targets the lower part of the respiratory tract and causes severe acute respiratory syndrom
Externí odkaz:
https://doaj.org/article/fca2cbcd7de646088a2ca4682ab44b55
Autor:
Andrés Antón, Candela Fernández-Naval, Iria Arrese-Muñoz, Juliana Esperalba, Mónica Martínez-Gallo, Ricardo Pujol-Borrell, Victoria Cardona, Tomás Pumarola, Moises Labrador-Horrillo, Victor Sanda, Manuel Hernández-González
Publikováno v:
Medicina Clinica
It is crucial to assess the levels of protection generated by natural infection or SARS-CoV-2 vaccines, mainly in individuals professionally exposed and in vulnerable groups. Measuring T-cell responses may complement antibody tests currently in use a
Autor:
Jin Gyu Jung, Sunghyun Kim, Bum Soo Kim, Anca Streinu-Cercel, Oana Săndulescu, Da Bee Jeon, Adrian Streinu-Cercel, Seul Gi Lee, Sang Joon Lee, Yeon Sook Kim, Yeo Jin Lee, Jin Yong Kim, Yeon Mi Lee, Min Kyung Kim, Jae-Hyeong Park, Jang Hee Hong, Jeong Eun Park, Young Rock Jang, Na Hyun Jung
Publikováno v:
Clinical Therapeutics
PURPOSE: Neutralizing antibodies can reduce SARS-CoV-2 cellular entry, viral titers, and pathologic damage. CT-P59 (regdanvimab), a SARS-CoV-2 neutralizing monoclonal antibody, was examined in 2 randomized, double-blind, placebo-controlled, single as
Autor:
Maurizio Federico
Publikováno v:
Cytokine & Growth Factor Reviews
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has given rise to the urgent need for vaccines and therapeutic interventions to address the spread of the SARS-CoV-2 virus. SARS-CoV-2 vaccines in development, and those being
Autor:
Volker Ast, Maximilian Kittel, Margot Thiaucourt, Verena Haselmann, Catharina Gerhards, Michael Neumaier, Michael Hetjens, Celine Becker
Publikováno v:
International Journal of Infectious Diseases, Vol 107, Iss, Pp 221-227 (2021)
International Journal of Infectious Diseases
International Journal of Infectious Diseases
INTRODUCTION: The longevity of antibody levels against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the duration of immunity are current topics of major scientific interest. Antibody kinetics during the acute phase are well studie
Autor:
Min Li, Jiaojiao Liu, Renfei Lu, Yuchao Zhang, Meng Du, Man Xing, Zhenchuan Wu, Xiangyin Kong, Yufei Zhu, Xianchao Zhou, Landian Hu, Chiyu Zhang, Dongming Zhou, Xia Jin
Publikováno v:
The Journal of Allergy and Clinical Immunology
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly pathogenic and contagious coronavirus that caused a global pandemic with 5.2 million fatalities to date. Questions concerning serologic features of long-term immunity
Publikováno v:
Case Studies in Chemical and Environmental Engineering, Vol 4, Iss, Pp 100105-(2021)
Case Studies in Chemical and Environmental Engineering
Case Studies in Chemical and Environmental Engineering
Transmissible Covid-19, caused by novel corona virus since last of 2019 has outspread widely until now. Where, India was the second most affected country and 3rd in mortality rate. In world ancient history, medicinal plants were played a crucial role
Publikováno v:
Journal of King Saud University: Science, Vol 33, Iss 4, Pp 101439-(2021)
Journal of King Saud University. Science
Journal of King Saud University. Science
By the end of year 2019, the new virus SARS-CoV-2 appeared, causing the Coronavirus Disease 2019 (COVID-19), and spread very fast globally. A continuing need for diagnostic tools is a must to contain its spread. Till now, the gold standard method, th
Autor:
Mark D. Gonzalez, Cristina Interiano, Mohamed Elkhalifa, Sheicho Muze, Elizabeth P Weinzierl, Brian Turner, Van Leung-Pineda, Robert C. Jerris, Beverly Barton Rogers
Publikováno v:
Practical Laboratory Medicine, Vol 25, Iss, Pp e00208-(2021)
Practical Laboratory Medicine
Practical Laboratory Medicine
Background Clinical laboratory testing has been an essential part of COVID-19 management. Serology can provide valuable information regarding a patient’s exposure to virus, and may have a larger role to play as vaccines becomes available. Limited d
Autor:
Christopher L. Haga, Mark Ballow
Publikováno v:
The Journal of Allergy and Clinical Immunology: In Practice
The Journal of Allergy and Clinical Immunology. in Practice
The Journal of Allergy and Clinical Immunology. in Practice
The year 2020 was a landmark year of a once-in-a-century pandemic of a novel coronavirus, SARS-CoV-2 virus, that led to a rapidly spreading coronavirus disease (COVID-19). The spectrum of disease with SARS-CoV-2 ranges from asymptomatic to mild upper